Microscopy & Microtechniques
Easing the way for pain-free insulin injections
Mar 13 2006
Author: Matthew Williamson, Novo Nordisk and Chris Keeping on behalf of Novo Nordisk A/S
There are an estimated 194 million diabetics worldwide and at the present rate of growth, this figure will exceed 333 million by 2025 [1]. Since some 17 million of the 194 million suffer from Type 1 diabetes and rely on regular injections of insulin, there is continuous effort by manufacturers of insulin delivery devices and needles to minimise the pain associated with these vital injections. Materials testing methods have an important role in ensuring that needles and needle assemblies meet the needs for safe handling and easy, pain-free injection.
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Oct 30 2024 Birmingham, UK
Oct 30 2024 Manchester, UK
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
